TMB and MSI were potential predictive markers for immunotherapy15,16,42, CKAP2L was positively correlated with TMB and MSI in most type cancers, indicating that patients with elevated CKAP2L expression in these tumors responded better to immunotherapy. The gene discussed is CKAP2L; the disease is cancer.